Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression - PubMed (original) (raw)
Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression
T Taga et al. J Exp Med. 1987.
Abstract
B cell stimulatory factor 2 receptors (BSF-2-R) were studied using radioiodinated recombinant BSF-2 with a specific activity of 6.16 X 10(13) cpm/g. Kinetic studies showed that binding of 125I-BSF-2 to CESS cells reached maximum level within 150 min at 0 degrees C. There was a single class of receptors with high affinity (Kd 3.4 X 10(-10) M) on CESS, and the number of receptors was 2,700 per cell. Binding of 125I-BSF-2 to CESS was competitively inhibited by unlabeled BSF-2 but not by IL-1, IL-2, IFN-beta, IFN-gamma, and G-CSF, indicating the presence of the receptors specific for BSF-2. EBV-transformed B lymphoblastoid cell lines (CESS, SKW6-CL4, LCL13, and LCL14) expressed BSF-2-R, whereas Burkitt's lines did not. EBV or EBNA2 did not induce the expression of the receptors on Burkitt's cells. The plasma cell lines (ARH-77 and U266) expressed BSF-2-R, fitting the function of BSF-2 as plasma cell growth factor. Several other cell lines, the histiocytic line U937, the promyelocytic line HL60, the astrocytoma line U373 and the glioblastoma line SK-MG-4, in which BSF-2 was inducible with IL-1 or TPA, displayed BSF-2-R with Kd in the range of 1.3-6.4 X 10(-10) M, suggesting the autocrine mechanism in BSF-2 function. The four T cell lines (CEM, HSB, Jurkat, and OM 1) did not express a detectable number of receptors, but normal resting T cells expressed 100-1,000 receptors per cell. BSF-2-R were not present on normal resting B cells but expressed on activated B cells with a Kd of 3.6-5.0 X 10(-10) M, fitting the function of BSF-2, which acts on B cells at the final maturation stage to induce immunoglobulin production.
Similar articles
- Characterization of the human B cell stimulatory factor 1 receptor.
Park LS, Friend D, Sassenfeld HM, Urdal DL. Park LS, et al. J Exp Med. 1987 Aug 1;166(2):476-88. doi: 10.1084/jem.166.2.476. J Exp Med. 1987. PMID: 3496417 Free PMC article. - Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G, Gerrard TL, Goldman NG, Pike SE. Tosato G, et al. J Immunol. 1988 Jun 15;140(12):4329-36. J Immunol. 1988. PMID: 2836512 - Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage.
Ohara J, Paul WE. Ohara J, et al. Nature. 1987 Feb 5-11;325(6104):537-40. doi: 10.1038/325537a0. Nature. 1987. PMID: 3100961 - Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS, Selemon H, Elton SM, Parinandi NL. Elton TS, et al. Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review. - Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.
Gordon J, Guy G, Walker L, Nathan P, Exley R, Clemens M. Gordon J, et al. Med Oncol Tumor Pharmacother. 1986;3(3-4):269-73. doi: 10.1007/BF02935004. Med Oncol Tumor Pharmacother. 1986. PMID: 3027466 Review.
Cited by
- Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells.
Snyers L, De Wit L, Content J. Snyers L, et al. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2838-42. doi: 10.1073/pnas.87.7.2838. Proc Natl Acad Sci U S A. 1990. PMID: 2157217 Free PMC article. - Regulation of IgE synthesis in humans.
Vercelli D, Geha RS. Vercelli D, et al. J Clin Immunol. 1989 Mar;9(2):75-83. doi: 10.1007/BF00916934. J Clin Immunol. 1989. PMID: 2654173 Review. No abstract available. - Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.
Mita S, Harada N, Naomi S, Hitoshi Y, Sakamoto K, Akagi M, Tominaga A, Takatsu K. Mita S, et al. J Exp Med. 1988 Sep 1;168(3):863-78. doi: 10.1084/jem.168.3.863. J Exp Med. 1988. PMID: 3262707 Free PMC article. - Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.
Le TT, Karmouty-Quintana H, Melicoff E, Le TT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, Molina J, Luo F, George AT, Garcia-Morales LJ, Bunge RR, Bruckner BA, Loebe M, Seethamraju H, Agarwal SK, Blackburn MR. Le TT, et al. J Immunol. 2014 Oct 1;193(7):3755-68. doi: 10.4049/jimmunol.1302470. Epub 2014 Aug 29. J Immunol. 2014. PMID: 25172494 Free PMC article. Clinical Trial. - Role of Interleukin 6 in Acute Pancreatitis: A Possible Marker for Disease Prognosis.
Mititelu A, Grama A, Colceriu MC, Benţa G, Popoviciu MS, Pop TL. Mititelu A, et al. Int J Mol Sci. 2024 Jul 29;25(15):8283. doi: 10.3390/ijms25158283. Int J Mol Sci. 2024. PMID: 39125854 Free PMC article. Review.
References
- Biochem J. 1983 May 15;212(2):259-64 - PubMed
- Immunol Lett. 1987 Jul;15(3):249-53 - PubMed
- J Exp Med. 1984 Nov 1;160(5):1450-66 - PubMed
- J Immunol. 1985 Feb;134(2):990-5 - PubMed
- EMBO J. 1985 Apr;4(4):933-9 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources